Lanreotide Acetate is used for treating acromegaly and neuroendocrine tumors. It was first introduced by Ipsen Pharma Biotech Sas in its drug Somatuline Depot on Aug 30, 2007. Another drug containing Lanreotide Acetate is Lanreotide Acetate. 2 different companies have introduced drugs containing Lanreotide Acetate.

Lanreotide Acetate Patents

Given below is the list of patents protecting Lanreotide Acetate, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Somatuline Depot	US5595760	Sustained release of peptides from pharmaceutical compositions	Mar 08, 2020 (Expired)	Ipsen Pharma

Add above patents to watchlist

Lanreotide Acetate's Family Patents

Full family tree

Lanreotide Acetate Generic API Manufacturers

Several generic applications have been filed for Lanreotide Acetate.

Given below is the list of companies who have filed for Lanreotide Acetate generic, along with the locations of their manufacturing plants worldwide.